

Eli Lilly & Co. has licensed the U.S. commercialization rights for the active ingredient in its erectile-dysfunction drug to United Therapeutics Corp. for uses as a high-blood-pressure treatment.
Primer Blog "específico" de Marketing Farmacéutico para países de habla hispana.
Eli Lilly & Co. has licensed the U.S. commercialization rights for the active ingredient in its erectile-dysfunction drug to United Therapeutics Corp. for uses as a high-blood-pressure treatment.
“Dum loquimur,
fugerit in vida aetas:
CARPE DIEM
quam minimum credula postero”
“Mientras hablamos,
habrá huido celosa la edad:
goza a bocados del momento,
confía lo menos posible
en el mañana”
No hay comentarios:
Publicar un comentario